The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus

Metformin is the first-line pharmacotherapy for treating type 2 diabetes mellitus (T2DM); however, its mechanism of modulating glucose metabolism is elusive. Recent advances have identified the gut as a potential target of metformin. As patients with metabolic disorders exhibit dysbiosis, the gut mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chae Bin, Chae, Soon Uk, Jo, Seong Jun, Jerng, Ui Min, Bae, Soo Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037857/
https://www.ncbi.nlm.nih.gov/pubmed/33808194
http://dx.doi.org/10.3390/ijms22073566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037857/
https://www.ncbi.nlm.nih.gov/pubmed/33808194
http://dx.doi.org/10.3390/ijms22073566

Ejemplares similares